Wellington Management Group LLP Apellis Pharmaceuticals, Inc. Transaction History
Wellington Management Group LLP
- $551 Billion
- Q1 2024
A detailed history of Wellington Management Group LLP transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 15,058,071 shares of APLS stock, worth $578 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
15,058,071Holding current value
$578 Million% of portfolio
0.16%Shares
18 transactions
Others Institutions Holding APLS
# of Institutions
337Shares Held
111MCall Options Held
1.26MPut Options Held
1.14M-
Eco R1 Capital, LLC San Francisco, CA11.4MShares$436 Million19.04% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$426 Million7.87% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.51MShares$365 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$211 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.61MShares$177 Million0.17% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $4.21B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...